Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
194M
-
Number of holders
-
301
-
Total 13F shares, excl. options
-
167M
-
Shares change
-
+2.97M
-
Total reported value, excl. options
-
$15.3B
-
Value change
-
+$283M
-
Put/Call ratio
-
0.68
-
Number of buys
-
173
-
Number of sells
-
-117
-
Price
-
$91.66
Significant Holders of INCYTE CORP - COMMON STOCK (INCY) as of Q1 2015
356 filings reported holding INCY - INCYTE CORP - COMMON STOCK as of Q1 2015.
INCYTE CORP - COMMON STOCK (INCY) has 301 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 167M shares
of 194M outstanding shares and own 86.47% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (22.4M shares), Capital World Investors (15.9M shares), WELLINGTON MANAGEMENT GROUP LLP (15.7M shares), BAKER BROS. ADVISORS LP (14.8M shares), VANGUARD GROUP INC (10M shares), JENNISON ASSOCIATES LLC (4.85M shares), Capital International Investors (4.29M shares), BlackRock Institutional Trust Company, N.A. (3.82M shares), BB BIOTECH AG (3.79M shares), and FMR LLC (3.79M shares).
This table shows the top 301 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.